Date: October 27, 1997 Comparison chart Chart 2 For years, peptides were the purview of immunologists and endocrinologists, but with the development of combinatorial chemistry and phage display libraries, the demand for peptides has skyrocketed. So too has the number of companies that provide custom peptide services. Once the bailiwick of a handful of companies, the field has burgeoned to close to 40 companies. The playing field is divided into at least two sectors: those companies with lon
| Date: October 27, 1997 | Comparison chart  Chart 2 |
What sets companies apart is the range of services provided along with the peptide. Some companies try to be full-service providers with, for example, capabilities for antibody production or oligo production ...
Memory-enhancing neural networks may also drive involuntary musical loops in the brain.
View this Issue
In this webinar, Brian Hie will discuss Evo2, a state-of-the-art genomic foundation model capable of generalist prediction and design tasks across DNA, RNA, and proteins.
In this webinar, learn how scientists use advanced human brain models to uncover treatment strategies for complex neurological conditions.
Manufacturing cell-based therapeutics requires a robust workflow from start to finish.
Modern DNA synthesis platforms empower researchers to explore the molecular world, from next-generation sequencing to cell and gene therapy development.
This new product line is specifically engineered to meet the rigorous demands of immunology research, vaccine development, animal studies, cell and gene therapy, and therapeutic protein manufacturing.
New fluidics and clog detection systems further simplify operation and reduce instrument downtime
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies
Study identifies new metrics to enhance scRNA-seq based virtual cell modelling
